Anhui Eastmark is a Manufacturer/Innovator company operating in the pharmaceutical industry.
Established in 2002, Anhui Eastmark Int’l Trading Co Ltd is devoted to manufacturing and developing pharmaceutical chemicals and biotechnology gene products serving pharmaceutical companies worldwide. Our main products: Anti-cancer, cardiovascular, antibiotic and biotech monoclone antibody. The hot products: Imipenem, Cilastatin Sodium, Meropenem, Tacrolimus, Moxidectin, Atracurium Besylate, and sevoflurane.From 2009, we started to expand our product range to Medical device, and after 15 years of development, now we can provide integrated solution for medical device.
Company type
Manufacturer/Innovator
Products and services
Finished Dosage Forms, APIs (Active Pharmaceutical Ingredients)
Markets
Oceania, North America (USA, Canada), Africa, Middle East Region (e.g. UAE), Central America (e.g. Mexico), East Asia (e.g. China, Japan, Korea), Europe – EU countries, Europe – non EU (e.g. UK, Russia, ex-CIS countries), South America (e.g. Brazil, Colombia), South Asia (e.g. India, Pakistan, Sri Lanka), South East Asia (e.g. Thailand, Philippines, Singapore)
Address
Anhui Eastmark, BUILDING A INTERNATIONAL FORTUNE CENTER, DONGLIU ROAD, HEFEI ANHUI, China, 230061
